OTC pediculicides
This article was originally published in The Tan Sheet
Executive Summary
NDMA submits citizen's petition to FDA and EPA on April 22, urging the agencies to "develop and implement a specific set of coordinating steps for the administrative transfer" of regulatory authority for pediculicides from EPA to FDA when the final OTC monograph on pediculicides becomes effective on Dec. 14. Actions requested in the petition echo those discussed at an April 14 "OTC feedback" meeting: an EPA stay of enforcement on FDA-labeled products prior to the effective date and a one-year grace period from FDA for EPA-labeled products in interstate commerce ("The Tan Sheet" April 18, p. 15). NDMA requested "expedited review" of the petition based on public health concerns and the "unique character of OTC pediculicide production and marketing"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning